|Articles|July 1, 2012
- Applied Clinical Trials-07-01-2012
- Volume 21
- Issue 7
Act cover
S
Advertisement
Cover
Articles in this issue
about 14 years ago
Managing Budgets in Complex Times with Tight Variancesabout 14 years ago
Business and News Update July 2012about 14 years ago
Increasing Intensity of On-Site Monitoring a Troubling Trendabout 14 years ago
Drug Information? Forget it!about 14 years ago
Supply Chain Managementabout 14 years ago
Developing Quality Biosimilarsabout 14 years ago
Drivers of Patient Interest in Referralabout 14 years ago
Risk-Based Monitoring Risky for Sponsors?about 14 years ago
Fresh Doubts Cast Over Post-Marketing Trialsabout 14 years ago
Health Reform Declared ConstitutionalAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced
2
Closing the Dead Time Gap in Clinical Data: Q&A with Raviv Pryluk, PhaseV
3
ACT Brief: Training Completion Versus Execution Readiness, AI Monitoring Agent Financial Value at Scale, and FDA Warning Letters and AI Oversight Gaps
4
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
5